Clinical Trial Update: Implementation of Up-front ctDNA Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - LM² Study

View source ↗

Summary

This clinical trial update outlines the LM² study's plan to implement upfront circulating tumor DNA testing in lung cancer care and to develop liquid biopsy–bas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Catharina Ziekenhuis Eindhoven | Conditions: Lung Cancer | Status: RECRUITING